BioMarin Pharmaceutical | BMRN - Işletim Giderleri





Işletim Giderleri Değişiklik Tarih
Acadia Pharmaceuticals USD 270.57M 450K 2026-09
Agios Pharmaceuticals USD 155.3M 24.53M 2026-06
Alnylam Pharmaceuticals USD 1.11B 52.78M 2026-09
Amgen USD 5.69B 6B 2026-09
Bayer EUR 9.92B 121M 2026-09
Biogen USD 2.32B 663.6M 2026-09
BioMarin Pharmaceutical USD 819.04M 5.5B 2026-09
Gilead Sciences USD 13.04B 9.09B 2026-09
Incyte USD 5.64B 4.67B 2026-09
Insmed USD 606.26M 79.46M 2026-09
Ionis Pharmaceuticals USD 370.24M 6.24M 2026-06
Moderna USD 1.18B 223M 2026-09
Neurocrine Biosciences USD 779.7M 40.6M 2026-09
PTC Therapeutics USD 211.54M 15.12M 2026-06
Puma Biotechnology USD 49.26M 3.2M 2024-06
Regeneron Pharmaceuticals USD 33.5B 1.79B 2026-09
Roche Holding CHF 18.9B 2.12B 2026-06
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Sanofi EUR 9.92B 941M 2026-06
Sarepta Therapeutics USD 390.39M 2.43M 2026-09
Ultragenyx Pharmaceutical USD 283M 6M 2026-09
United Therapeutics USD 6.28B 124.3M 2026-09
Vertex Pharmaceuticals USD 2.18B 118.2M 2026-09